17-beta hydroxysteroid dehydrogenase 3 deficiency is a rare inherited condition that disrupts male sexual development. Affected people are genetically male, with one X and one Y chromosome and testes, but the testes make too little testosterone because a variant of the HSD17B3 gene leaves the enzyme that converts androstenedione to testosterone with little or no activity. Before birth the shortage of testosterone prevents the external sex organs from forming in the usual male pattern, so most affected infants have genitalia that look female, some look ambiguous, and some look mostly male with a small penis or hypospadias. At puberty other tissues produce more testosterone and male secondary sex characteristics appear, sometimes with breast enlargement, although affected people are generally infertile. The condition is inherited in an autosomal recessive pattern and occurs in about 1 in 147,000 newborns, far more often among the Arab population of Gaza.
Facts
Classification
ICD-10 ChapterIV: Endocrine, Nutritional and Metabolic Diseases 2 Communicable or Non-communicable Transmission Route Causative Agent
Causative Agent (category) Sources
1. 17-beta hydroxysteroid dehydrogenase 3 deficiency (MedlinePlus Genetics page)
Description, first sentence
is a condition that affects male sexual development
Description, first paragraph
Their bodies, however, do not produce enough of a male sex hormone (androgen) called testosterone.
Causes
Mutations in the HSD17B3 gene cause 17-beta hydroxysteroid dehydrogenase 3 deficiency.
Inheritance
This condition is inherited in an autosomal recessive pattern
View the Source2. Orphanet (Orphadata): Orphadata: Rare diseases with ICD-10 and ICD-11 mappings (en_product1)
Orphanet (Orphadata)Orphanet entry ORPHA:752, Validated ICD-10 mappingQuote, Orphanet entry ORPHA:752, Validated ICD-10 mapping
ICD-10 E29.1
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.